(Q37153817)

18 August 2017

3 references

22 June 2019

19 September 2019

27 August 2020

Adaptive design methods in clinical trials - a review (English)

1 reference

biomedical investigative technique

18 August 2017

1 reference

19 September 2019

1 reference

27 August 2020

Shein-Chung Chow

1 reference

18 August 2017

Mark Chang

series ordinal

1 reference

18 August 2017

2 May 2008

4 references

Orphanet Journal of Rare Diseases

18 August 2017

22 June 2019

19 September 2019

27 August 2020

4 references

18 August 2017

22 June 2019

19 September 2019

27 August 2020

1 reference

18 August 2017

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2017

3 references

22 June 2019

19 September 2019

Adaptive group sequential test for clinical trials with changing patient population

27 August 2020

copyrighted

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Adapting the sample size planning of a phase III trial based on phase II data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Testing and estimation in flexible group sequential designs with adaptive treatment selection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Adaptive statistical analysis following sample size modification based on interim review of effect size

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Two-stage sample size re-estimation based on a nuisance parameter: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Meta-analyses and adaptive group sequential designs in the clinical development process

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Statistical properties of randomization in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Group sequential procedures: calendar versus information time

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

An adaptive method for establishing a dose-response relationship

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Approximately optimal one-parameter boundaries for group sequential trials.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Continual reassessment method: a practical design for phase 1 clinical trials in cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

FDA introductory comments: clinical studies design and evaluation issues.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

When (not) to stop a clinical trial for benefit.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

An adaptive dose-finding design incorporating both toxicity and efficacy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Drop-the-losers design: normal case.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Statistical consideration of adaptive methods in clinical development.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Adaptive urn designs for estimating several percentiles of a dose--response curve

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Optimal adaptive designs for binary response trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Adaptive sample size calculations in group sequential trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Modification of sample size in group sequential clinical trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

On sample size and inference for two-stage adaptive designs

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Continual reassessment method: a likelihood approach.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Select a Single Treatment From Several

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422839

Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group

4 December 2018

1 reference

12 December 2020

Adaptive design method based on sum of p-values

1 reference

12 December 2020

Statistical analysis for two-stage seamless design with different study endpoints

1 reference

12 December 2020

Estimating a treatment effect in survival studies in which patients switch treatment

1 reference

12 December 2020

Designed extension of studies based on conditional power

1 reference

12 December 2020

Combining different phases in the development of medical treatments within a single trial

1 reference

12 December 2020

Inference for clinical trials with some protocol amendments

1 reference

12 December 2020

A hybrid Bayesian adaptive design for dose response trials.

1 reference

12 December 2020

Identifiers

DOI

10.1186/1750-1172-3-11

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

18454853

1 reference